|
시장보고서
상품코드
1762417
세계의 인유두종 바이러스 검사 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 제품별, 용도별, 기술별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Human Papillomavirus Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Instruments, Consumables, Services), By Application, By Technology, By End-use, and Region- Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 인간유두종바이러스(HPV) 검사 세계 시장 규모는 2034년까지 55억 4,792만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
인유두종 바이러스(HPV) 검사 시장은 생물학적 샘플에서 HPV 바이러스의 존재를 검출하는 데 사용되는 진단 검사의 판매 및 유통을 포함합니다. 주로 여성 건강에 사용되는 이러한 검사는 특정 고위험 HPV 유전자형의 지속적인 감염이 이 질환의 주요 원인이기 때문에 자궁경부암 검진에 중요한 역할을 하고 있습니다. 이 시장에는 HPV DNA 또는 RNA를 식별하는 분자 검사 등 다양한 검사 방법, 관련 기기, 소모품, 검사 기관 및 의료 서비스 제공업체가 제공하는 검사 서비스가 포함됩니다.
인유두종 바이러스 검사 시장은 HPV와 자궁경부암의 연관성에 대한 인식 증가, 전국적인 자궁경부암 검진 프로그램 시행, 진단 기술의 발전 등을 배경으로 크게 성장하고 있습니다. 주요 시장 성장 촉진요인은 HPV 검사를 1차 검진 도구로 사용하거나 기존 HPV 검사 및 PAP 검사와 함께 사용하는 움직임이 확산되고 있다는 점입니다. 또한, 보다 민감하고 특이적인 HPV 분석법의 개발과 자가 채취 옵션의 도입으로 시장 침투와 접근성이 향상되고 있습니다. 진행 중인 연구, 암 조기 발견에 대한 시장 수요 증가, 예방적 건강 관리를 장려하는 정부의 적극적인 노력에 힘입어 시장 전망은 계속 밝을 것으로 예측됩니다.
인유두종 바이러스 검사 시장 보고서 - 주요 내용
응용 분야별로 보면, 자궁경부암 검진 하위 부문이 현재 세계 최대 시장 점유율을 차지하고 있습니다. 이는 일상적인 검진 프로그램에서의 역할이 확립되어 있고, 전암 병변의 조기 발견에 대한 중요성이 강조되고 있기 때문입니다.
제품별로는 시약, 분석 키트 및 기타 일회용 재료는 전 세계적으로 HPV 검사가 대량으로 시행되는 선별 및 진단을 위해 반복적으로 필요하기 때문에 소모품 하위 부문이 가장 큰 시장 점유율을 차지하고 있습니다.
기술별로는 PCR 기반 분석이 HPV DNA 검출에 있어 높은 민감도와 특이성으로 인해 PCR 하위 부문이 가장 큰 시장 점유율을 차지하며 전 세계적으로 자궁경부암 검진에 선호되는 기술로 자리 잡았습니다.
최종 용도별로는 병원 및 클리닉이 가장 큰 시장 점유율을 차지하고 있습니다. 이러한 의료 환경은 자궁경부암 검진 및 진단 과정을 정기적으로 받는 인구의 대다수에게 주요 진료소 역할을 하고 있기 때문입니다.
지역별로는 북미가 현재 인유두종 바이러스 검사 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 아시아태평양은 예측 기간 동안 인유두종 바이러스 검사 시장에서 가장 높은 성장률을 보일 것으로 예측됩니다.
인간유두종 바이러스 검사 시장에서 활발하게 활동하는 주요 기업으로는 QIAGEN N.V., F. Hoffmann-La Roche AG, Hologic, Inc. Thermo Fisher Scientific Inc., Danaher Corporation(Cepheid), bioMerieux S.A., GenMark Diagnostics, Inc. Luminex Corporation(DiaSorin S.p.A.) 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 인유두종 바이러스 검사 시장 인사이트
- 시장 현황
- 인유두종 바이러스 검사 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 인유두종 바이러스 검사 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 인유두종 바이러스 검사 시장 : 용도별
- 주요 조사 결과
- 서론
- 자궁경부암 검진
- 질암 검진
제6장 세계의 인유두종 바이러스 검사 시장 : 제품별
- 주요 조사 결과
- 서론
- 기기
- 소모품
- 서비스
제7장 세계의 인유두종 바이러스 검사 시장 : 기술별
- 주요 조사 결과
- 서론
- PCR
- 면역진단
- 기타 기술
제8장 세계의 인유두종 바이러스 검사 시장 : 최종 용도별
- 주요 조사 결과
- 서론
- 병원 및 진료소
- 실험실
- 기타
제9장 세계의 인유두종 바이러스 검사 시장 : 지역별
- 주요 조사 결과
- 서론
- 인유두종 바이러스 검사 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 용도별, 2020-2034년
- 북미 : 제품별, 2020-2034년
- 북미 : 기술별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 용도별, 2020-2034년
- 유럽 : 제품별, 2020-2034년
- 유럽 : 기술별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 기술별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 기술별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 기술별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 개요
- Abbott Laboratories
- Agilent Technologies, Inc.
- Becton, Dickinson and Company(BD)
- bioMerieux S.A.
- Danaher Corporation(Cepheid)
- F. Hoffmann-La Roche AG
- GenMark Diagnostics, Inc.(acquired by Roche)
- Hologic, Inc.
- Luminex Corporation(DiaSorin S.p.A.)
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
The global human papillomavirus (HPV) testing market size is expected to reach USD 5,547.92 Million by 2034, according to a new study by Polaris Market Research. The report "Human Papillomavirus Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Instruments, Consumables, Services), By Application, By Technology, By End-use, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The human papillomavirus (HPV) testing market encompasses the sale and distribution of diagnostic tests used to detect the presence of the HPV virus in biological samples. Primarily utilized in women's health, these tests play a critical role in screening for cervical cancer, as persistent infections with certain high-risk HPV genotypes are the primary cause of this disease. The market includes various testing methodologies, such as molecular tests that identify HPV DNA or RNA, as well as related instruments, consumables, and testing services offered by laboratories and healthcare providers.
The human papillomavirus testing market is experiencing significant growth, driven by increasing awareness of the link between HPV and cervical cancer, the implementation of national cervical cancer screening programs, and advancements in diagnostic technologies. A key market drive is the growing adoption of HPV testing as a primary screening tool or in conjunction with traditional HPV and Pap test. Furthermore, the development of more sensitive and specific HPV assays, along with the introduction of self-sampling options, is enhancing market penetration and accessibility. The market outlook remains positive, fueled by ongoing research, increasing market demand for early cancer detection, and supportive government initiatives promoting preventive healthcare.
Human Papillomavirus Testing Market Report Highlights:
By application, the cervical cancer screening subsegment currently holds the largest market share globally due to its established role in routine screening programs and the strong emphasis on early detection of precancerous lesions.
By product, the consumables subsegment accounts for the largest market share because of the recurring need for reagents, assay kits, and other disposable materials in the high volume of HPV testing procedures conducted worldwide for screening and diagnosis.
By technology, the PCR subsegment commands the largest market share owing to the high sensitivity and specificity of PCR-based assays in detecting HPV DNA, making it the preferred technology for cervical cancer screening on a global scale.
By end-use, the hospitals & clinics subsegment holds the largest market share as these healthcare settings serve as the primary points of care for a significant portion of the population undergoing routine cervical cancer screening and diagnostic processes.
By region, North America currently holds the largest market share in the human papillomavirus testing market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the human papillomavirus testing market over the forecast period.
Some of the major players actively operating in the human papillomavirus testing market include QIAGEN N.V., F. Hoffmann-La Roche AG, Hologic, Inc., Abbott Laboratories, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Danaher Corporation (Cepheid), bioMerieux S.A., GenMark Diagnostics, Inc. (acquired by Roche), Agilent Technologies, Inc., and Luminex Corporation (DiaSorin S.p.A.).
Polaris Market Research has segmented the Human Papillomavirus Testing market report based on application, product, technology, end-use, and region:
By Application Outlook (Revenue - USD Million, 2020-2034)
Cervical Cancer Screening
Vaginal Cancer Screening
By Product Outlook (Revenue - USD Million, 2020-2034)
Instruments
Consumables
Services
By Technology Outlook (Revenue - USD Million, 2020-2034)
PCR
Immunodiagnostics
Other Technologies
By End-Use Outlook (Revenue - USD Million, 2020-2034)
Hospitals & Clinics
Laboratories
Others
By Regional Outlook (Revenue - USD Million, 2020-2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Human Papillomavirus Testing Market Insights
- 4.1. Human Papillomavirus Testing Market - Market Snapshot
- 4.2. Human Papillomavirus Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Awareness and Screening Programs
- 4.2.1.2. Technological Advancements in Testing Methods
- 4.2.1.3. Increasing Prevalence of HPV Infections
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Low awareness and screening rates
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Human Papillomavirus Testing Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Human Papillomavirus Testing Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 5.3. Cervical Cancer Screening
- 5.3.1. Global Human Papillomavirus Testing Market, by Cervical Cancer Screening, by Region, 2020-2034 (USD Million)
- 5.4. Vaginal Cancer Screening
- 5.4.1. Global Human Papillomavirus Testing Market, by Vaginal Cancer Screening, by Region, 2020-2034 (USD Million)
6. Global Human Papillomavirus Testing Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 6.3. Instruments
- 6.3.1. Global Human Papillomavirus Testing Market, by Instruments, by Region, 2020-2034 (USD Million)
- 6.4. Consumables
- 6.4.1. Global Human Papillomavirus Testing Market, by Consumables, by Region, 2020-2034 (USD Million)
- 6.5. Services
- 6.5.1. Global Human Papillomavirus Testing Market, by Services, by Region, 2020-2034 (USD Million)
7. Global Human Papillomavirus Testing Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 7.3. PCR
- 7.3.1. Global Human Papillomavirus Testing Market, by PCR, by Region, 2020-2034 (USD Million)
- 7.4. Immunodiagnostics
- 7.4.1. Global Human Papillomavirus Testing Market, by Immunodiagnostics, by Region, 2020-2034 (USD Million)
- 7.5. Other Technologies
- 7.5.1. Global Human Papillomavirus Testing Market, by Other Technologies, by Region, 2020-2034 (USD Million)
8. Global Human Papillomavirus Testing Market, by End-Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 8.3. Hospitals & Clinics
- 8.3.1. Global Human Papillomavirus Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
- 8.4. Laboratories
- 8.4.1. Global Human Papillomavirus Testing Market, by Laboratories, by Region, 2020-2034 (USD Million)
- 8.5. Others
- 8.5.1. Global Human Papillomavirus Testing Market, by Others, by Region, 2020-2034 (USD Million)
9. Global Human Papillomavirus Testing Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Human Papillomavirus Testing Market Assessment, By Geography, 2020-2034 (USD Million)
- 9.3. Human Papillomavirus Testing Market - North America
- 9.3.1. North America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.3.2. North America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.3.3. North America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.3.4. North America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.3.5. Human Papillomavirus Testing Market - US
- 9.3.5.1. US: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.3.5.2. US: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.3.5.3. US: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.3.5.4. US: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.3.6. Human Papillomavirus Testing Market - Canada
- 9.3.6.1. Canada: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.3.6.2. Canada: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.3.6.3. Canada: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.3.6.4. Canada: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4. Human Papillomavirus Testing Market - Europe
- 9.4.1. Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.2. Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.3. Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.4. Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4.5. Human Papillomavirus Testing Market - UK
- 9.4.5.1. UK: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.5.2. UK: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.5.3. UK: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.5.4. UK: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4.6. Human Papillomavirus Testing Market - France
- 9.4.6.1. France: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.6.2. France: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.6.3. France: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.6.4. France: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4.7. Human Papillomavirus Testing Market - Germany
- 9.4.7.1. Germany: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.7.2. Germany: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.7.3. Germany: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.7.4. Germany: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4.8. Human Papillomavirus Testing Market - Italy
- 9.4.8.1. Italy: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.8.2. Italy: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.8.3. Italy: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.8.4. Italy: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4.9. Human Papillomavirus Testing Market - Spain
- 9.4.9.1. Spain: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.9.2. Spain: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.9.3. Spain: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.9.4. Spain: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4.10. Human Papillomavirus Testing Market - Netherlands
- 9.4.10.1. Netherlands: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.10.2. Netherlands: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.10.3. Netherlands: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.10.4. Netherlands: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4.11. Human Papillomavirus Testing Market - Russia
- 9.4.11.1. Russia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.11.2. Russia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.11.3. Russia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.11.4. Russia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.4.12. Human Papillomavirus Testing Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.4.12.2. Rest of Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.4.12.3. Rest of Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.4.12.4. Rest of Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5. Human Papillomavirus Testing Market - Asia Pacific
- 9.5.1. Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5.5. Human Papillomavirus Testing Market - China
- 9.5.5.1. China: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.5.2. China: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.5.3. China: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.5.4. China: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5.6. Human Papillomavirus Testing Market - India
- 9.5.6.1. India: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.6.2. India: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.6.3. India: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.6.4. India: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5.7. Human Papillomavirus Testing Market - Malaysia
- 9.5.7.1. Malaysia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.7.2. Malaysia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.7.3. Malaysia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.7.4. Malaysia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5.8. Human Papillomavirus Testing Market - Japan
- 9.5.8.1. Japan: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.8.2. Japan: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.8.3. Japan: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.8.4. Japan: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5.9. Human Papillomavirus Testing Market - Indonesia
- 9.5.9.1. Indonesia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.9.2. Indonesia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.9.3. Indonesia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.9.4. Indonesia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5.10. Human Papillomavirus Testing Market - South Korea
- 9.5.10.1. South Korea: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.10.2. South Korea: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.10.3. South Korea: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.10.4. South Korea: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5.11. Human Papillomavirus Testing Market - Australia
- 9.5.11.1. Australia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.11.2. Australia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.11.3. Australia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.11.4. Australia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.5.12. Human Papillomavirus Testing Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.5.12.2. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.5.12.3. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.5.12.4. Rest of Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.6. Human Papillomavirus Testing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.6.5. Human Papillomavirus Testing Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.6.5.2. Saudi Arabia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.6.5.3. Saudi Arabia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.6.5.4. Saudi Arabia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.6.6. Human Papillomavirus Testing Market - UAE
- 9.6.6.1. UAE: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.6.6.2. UAE: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.6.6.3. UAE: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.6.6.4. UAE: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.6.7. Human Papillomavirus Testing Market - Israel
- 9.6.7.1. Israel: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.6.7.2. Israel: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.6.7.3. Israel: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.6.7.4. Israel: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.6.8. Human Papillomavirus Testing Market - South Africa
- 9.6.8.1. South Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.6.8.2. South Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.6.8.3. South Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.6.8.4. South Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.6.9. Human Papillomavirus Testing Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.6.9.2. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.6.9.3. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.6.9.4. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.7. Human Papillomavirus Testing Market - Latin America
- 9.7.1. Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.7.2. Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.7.3. Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.7.4. Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.7.5. Human Papillomavirus Testing Market - Mexico
- 9.7.5.1. Mexico: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.7.5.2. Mexico: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.7.5.3. Mexico: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.7.5.4. Mexico: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.7.6. Human Papillomavirus Testing Market - Brazil
- 9.7.6.1. Brazil: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.7.6.2. Brazil: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.7.6.3. Brazil: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.7.6.4. Brazil: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.7.7. Human Papillomavirus Testing Market - Argentina
- 9.7.7.1. Argentina: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.7.7.2. Argentina: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.7.7.3. Argentina: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.7.7.4. Argentina: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
- 9.7.8. Human Papillomavirus Testing Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
- 9.7.8.2. Rest of Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
- 9.7.8.3. Rest of Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
- 9.7.8.4. Rest of Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Agilent Technologies, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Becton, Dickinson and Company (BD)
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. bioMerieux S.A.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Danaher Corporation (Cepheid)
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. F. Hoffmann-La Roche AG
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. GenMark Diagnostics, Inc. (acquired by Roche)
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Hologic, Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Luminex Corporation (DiaSorin S.p.A.)
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. QIAGEN N.V.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Thermo Fisher Scientific Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
